Katharina Elisabeth Grafinger

Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland

Katharina Elisabeth Grafinger, Severine Krönert, Alain Broillet et al. · Forensic Science International · 2020 · 46 citations

Cannabis Use, Substance Abuse, Drug Analysis +8

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB₁ receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay

Katharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski et al. · Drug Testing and Analysis · 2021 · 41 citations

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB₁ receptor activation assays: Part I—Synthesis, analytical characterization, and binding affinity for human CB₁ receptors

Edward Pike, Katharina Elisabeth Grafinger, Annelies Cannaert et al. · Drug Testing and Analysis · 2021 · 39 citations

Study of the <i>in vitro</i> and <i>in vivo</i> metabolism of the tryptamine 5‐MeO‐MiPT using human liver microsomes and real case samples

Katharina Elisabeth Grafinger, Marianne Hädener, Stefan König et al. · Drug Testing and Analysis · 2017 · 29 citations · Full text

Forensic Chemistry, Real Case Samples, Aggressive Behavior +27

Structure–activity relationships of valine, <i>tert</i>-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA

Eric Sparkes, Elizabeth A. Cairns, Richard C. Kevin et al. · RSC Medicinal Chemistry · 2021 · 27 citations · Full text